Naso-(NP) and oro-pharyngeal (OP) cross-sectional area (CSA) and airflow response to genioglossus (GG) contraction in patients with obstructive sleep apnea (OSA)

A. Oliven, N. Tov, M. Odeh, L. Geitini, U. Steinfeld, R. Oliven, A. R. Schwartz (Haifa, Israel; Baltimore, United States Of America)

Source: Annual Congress 2004 - Non-CPAP therapy for OSA
Session: Non-CPAP therapy for OSA
Session type: Oral Presentation
Number: 2998
Disease area: Sleep and breathing disorders

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Oliven, N. Tov, M. Odeh, L. Geitini, U. Steinfeld, R. Oliven, A. R. Schwartz (Haifa, Israel; Baltimore, United States Of America). Naso-(NP) and oro-pharyngeal (OP) cross-sectional area (CSA) and airflow response to genioglossus (GG) contraction in patients with obstructive sleep apnea (OSA). Eur Respir J 2004; 24: Suppl. 48, 2998

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Upper airway (UAW) pressure-flow response to electrical stimulation (ES) of tongue protrusors (TP) and retractors (TR) in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2001; 18: Suppl. 33, 332s
Year: 2001

Pharyngeal compliance (Cph) in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 641s
Year: 2006

Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Prevalence and causes of residual sleepiness (RS) 12 months after continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea syndome (OSAS)
Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness
Year: 2010

Long-term effects of noninvasive mechanical ventilation (NMV) in COPD patients with obstructive sleep apnoea (OSA) (overlap syndrome)
Source: Eur Respir J 2001; 18: Suppl. 33, 402s
Year: 2001

Effect of nCPAP on work performance (WP) in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 725s
Year: 2005

Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020


Influence of nasal obstruction (NO) on obstructive sleep apnea (OSA) severity and continuous positive airway pressure (CPAP) adaptation problems
Source: Annual Congress 2010 - The upper airway and oral appliances
Year: 2010

Neural respiratory drive (NRD) during continuous positive airway pressure (CPAP) titration in awake obese subjects with obstructive sleep apnoea (OSA)
Source: International Congress 2015 – A bout de souffle: hypoxia and sleep-disordered breathing
Year: 2015

CPAP-induced changes in upper airway (UA) dynamics assessed with magnetic phrenic nerve stimulation in awake obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2001; 18: Suppl. 33, 331s
Year: 2001

Relationship between nerve tissue and inflammatory cell infiltration in the upper airway (UA) of obstructive sleep apnoea (OSA) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 445s
Year: 2004

Outcomes in patients with REM-related obstructive sleep apnoea (REM-OSA) treated with continuous positive airway pressure (CPAP)
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019


Relationship between anthropometric parameters, sleep disordered breathing and airway inflammation (AI) in obese adults affected by obstructive sleep apnea (OSA)
Source: Eur Respir J 2004; 24: Suppl. 48, 118s
Year: 2004

Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Source: Sleep and Breathing Conference 2021
Year: 2021

Catecholamines and obstructive sleep apnea (OSA) severity: response to positive airway pressure (PAP) therapy
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009


Polysomnographic profile of patients with fibromyalgia (FMS) and obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 567s
Year: 2005

The effect of volume targeted pressure support (PS) ventilation with autotitrating expiratory positive airways pressure (EPAP) and back up rate (BUR) on sleep quality in COPD-obstructive sleep apnoea (OSA) overlap syndrome
Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Year: 2013

Mechanical interaction between the tongue and the velopharynx in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2010 - The upper airway and oral appliances
Year: 2010


Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

Cardiohemodynamics parameters in patients with COPD and obstructive sleep apnea, (OSA).
Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea
Year: 2017